About: Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? No

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? No Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/bmj/2007/volume_334/issue_7601/w
Subject	Drugs: cardiovascular system Epidemiologic studies Feature Ischaemic heart disease Health promotion Clinical trials (epidemiology)
Title	Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? No
has manifestation of work	http://hub.abes.fr/bmj/periodical/bmj/2007/volume_334/issue_7601/B36E2DCCD2302CFCE053120B220AC69C/m/web http://hub.abes.fr/bmj/periodical/bmj/2007/volume_334/issue_7601/B36E2DCCD2302CFCE053120B220AC69C/m/print
related by	http://hub.abes.fr/bmj/periodical/bmj/2007/volume_334/issue_7601/B36E2DCCD2302CFCE053120B220AC69C/authorship/1
Abstract	Women in western countries are more likely to die from heart disease than from cancer. Scott M Grundy argues that the risks make preventive treatment essential, but Malcolm Kendrick believes the evidence of benefit is not strong enough
article type	other
publisher identifier	kenm465476
is part of this journal	British Medical Journal
PubMed ID	17494018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata